the jda, page-19

I agree with your comment that the contract will cover 5 years or life of patent, whichever is longer, as noted in last years's ann.
I would expect most patents to exceed the 5 years time span as many patents were only lodged last year.

As for payments, the FMCG claims access rights for that period,which is just another expression for exclusivity rights, development period included and will have to be financially covered.

Under the Strategic Alliance, OBJ will work exclusively
with the FMCG company in specific product areas and the FMCG company will work exclusively with OBJ in enhanced delivery.


We also look at beauty care products with short regulatory hurdles attached as we would deliver compounds already being commercially sold by the company.

The FMCG2 development speed has so far surprised holders and I have the feeling that it will continue to do so as this program seems to be aggressive and quickly progressing in nature.
Reason for that would be the widely applied innovation push for all 3 technologies we offer in multpiple product ranges.

This company wants to overhaul either its entire or vast parts of its product range with our technology.
I would therefore expect speedy updates and negotiations to be concluded shortly.

One would need to consider that negotiation points are well outlayed already before we received this ann as both parties have spent much time with each other over the last year. Discussions did not start the day after the ann, they would be well outlined as it is and ready prior to successful completion of the testing phase.